IL6 and breast carcinoma: Breast cancer cell-derived IL-6 promotes IL-6 and IL6Rα expression in MDSCs, and IL-6 trans-signaling in cancer cells activates STAT phosphorylation, thereby promoting breast cancer invasion and metastasis in a mouse model established through a xenograft of human breast cancer cells [46,144].